Skip to content
777 Sourcing.

Capability

quantitative trait loci mapping

Suppliers
1
States & provinces
1
Countries
1

1 quantitative trait loci mapping supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

IKAIKA THERAPEUTICS INC

OAK PARK, IL

Ikaika Therapeutics is a biotech company developing first-in-class anti-fibrotic antibodies, including IKN-001, which binds LTBP4 to prevent TGF-β activation and fibrosis accumulation. Its pipeline targets fibrotic diseases including muscular dystrophy, based on genetic research identifying LTBP4 as a driver of fibrotic disease severity.

antibody developmentgenetic researchgenome-wide mapping

Compiled from public sources

Related capabilities

Other processes offered by the shops that list quantitative trait loci mapping.

Browse all capabilities